GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Daiichi Sankyo Co Ltd (TSE:4568) » Definitions » Cyclically Adjusted Revenue per Share

Daiichinkyo Co (TSE:4568) Cyclically Adjusted Revenue per Share : 円645.31 (As of Mar. 2025)


View and export this data going back to 2005. Start your Free Trial

What is Daiichinkyo Co Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Daiichinkyo Co's adjusted revenue per share for the three months ended in Mar. 2025 was 円273.357. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is 円645.31 for the trailing ten years ended in Mar. 2025.

During the past 12 months, Daiichinkyo Co's average Cyclically Adjusted Revenue Growth Rate was 12.50% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 9.50% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 6.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Daiichinkyo Co was 9.50% per year. The lowest was 0.90% per year. And the median was 1.40% per year.

As of today (2025-06-30), Daiichinkyo Co's current stock price is 円3297.00. Daiichinkyo Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 was 円645.31. Daiichinkyo Co's Cyclically Adjusted PS Ratio of today is 5.11.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Daiichinkyo Co was 10.34. The lowest was 1.68. And the median was 5.40.


Daiichinkyo Co Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Daiichinkyo Co's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Daiichinkyo Co Cyclically Adjusted Revenue per Share Chart

Daiichinkyo Co Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 478.64 491.96 523.22 573.53 645.31

Daiichinkyo Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 573.53 590.50 606.42 627.77 645.31

Competitive Comparison of Daiichinkyo Co's Cyclically Adjusted Revenue per Share

For the Drug Manufacturers - General subindustry, Daiichinkyo Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Daiichinkyo Co's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Daiichinkyo Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Daiichinkyo Co's Cyclically Adjusted PS Ratio falls into.


;
;

Daiichinkyo Co Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Daiichinkyo Co's adjusted Revenue per Share data for the three months ended in Mar. 2025 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=273.357/111.1000*111.1000
=273.357

Current CPI (Mar. 2025) = 111.1000.

Daiichinkyo Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201506 112.968 98.400 127.548
201509 116.114 98.500 130.967
201512 136.160 98.100 154.204
201603 110.902 97.900 125.855
201606 117.291 98.100 132.834
201609 106.974 98.000 121.274
201612 138.302 98.400 156.152
201703 110.644 98.100 125.306
201706 119.888 98.500 135.224
201709 115.454 98.800 129.827
201712 136.574 99.400 152.650
201803 111.670 99.200 125.066
201806 115.909 99.200 129.813
201809 113.524 99.900 126.251
201812 131.551 99.700 146.593
201903 116.359 99.700 129.664
201906 127.964 99.800 142.453
201909 118.251 100.100 131.246
201912 142.445 100.500 157.469
202003 115.391 100.300 127.816
202006 121.647 99.900 135.285
202009 124.864 99.900 138.863
202012 132.974 99.300 148.776
202103 116.082 99.900 129.096
202106 137.649 99.500 153.697
202109 138.595 100.100 153.825
202112 146.467 100.100 162.562
202203 121.929 101.100 133.989
202206 146.110 101.800 159.458
202209 170.688 103.100 183.932
202212 177.461 104.100 189.394
202303 172.105 104.400 183.150
202306 182.859 105.200 193.114
202309 195.709 106.200 204.739
202312 232.934 106.800 242.312
202403 223.290 107.200 231.413
202406 227.684 108.200 233.786
202409 233.775 108.900 238.498
202412 254.688 110.700 255.608
202503 273.357 111.100 273.357

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Daiichinkyo Co  (TSE:4568) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Daiichinkyo Co's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=3297.00/645.31
=5.11

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Daiichinkyo Co was 10.34. The lowest was 1.68. And the median was 5.40.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Daiichinkyo Co Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Daiichinkyo Co's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Daiichinkyo Co Business Description

Industry
Traded in Other Exchanges
Address
3-5-1, Nihonbashi-honcho, Chuo-ku, Tokyo, JPN, 103-8426
Daiichi Sankyo was established by the merger of Daiichi Pharmaceuticals and Sankyo in 2005. As of 2024, approximately one quarter of revenue comes from its Japan businesses, which will shrink in the future as the company expands its global footprint. Its primary growth driver is its leading platform of antibody drug conjugates, or ADCs. Its three lead ADCs are Enhertu (HER2), Datroway (TROP2), I-DXd (B7-H3), HER3-DXd (HER3), and R-DXd (CDH6). Enhertu entered the clinic in 2015 and received its first US approval in December 2019 for third-line late-stage HER2-positive breast cancer. It is also approved for HER2-positive stomach cancers and HER2 mutant non-small cell lung cancer.

Daiichinkyo Co Headlines

No Headlines